GlassScriptPhysician profile
Thy K Nguyen
NPI 1053352112
$416.52
in general payments reported to CMS, 2019-2025
17 companies · $68.64 in 2025
The $68.64 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $72.93 · 2022: $72.97 · 2023: $54.56 · 2024: $147 · 2025: $68.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $207 · Education: $63.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $206.70 |
| Education | $63.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $57.64 | 2022-2025 | |
| Pfizer INC. | $52.79 | 2022-2024 | |
| Janssen Biotech, INC. | $42.04 | 2024-2025 | Rybrevant |
| Abbvie INC. | $40.07 | 2021 | |
| Sumitomo Pharma America, INC. | $23.93 | 2023 | Orgovyx |
| Alexion Pharmaceuticals, INC. | $23.91 | 2024 | Ultomiris |
| Array Biopharma INC | $22.80 | 2022 | |
| Sobi, INC | $21.55 | 2024 | |
| Puma Biotechnology, INC. | $20.94 | 2021 | |
| Daiichi Sankyo INC. | $19.96 | 2024 | Enhertu |
| Tempus Ai, INC | $19.93 | 2024 | |
| Seagen INC. | $15.62 | 2023 | Padcev |
| E.R. Squibb & Sons, L.L.C. | $15.01 | 2023 | Opdivo |
| Astrazeneca Pharmaceuticals LP | $14.48 | 2025 | Enhertu |
| Acrotech Biopharma INC. | $13.93 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $11.92 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thy Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.